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Background: Gastrointestinal dysmotility may be involved in the development of bacterial translocation and
infection in patients with liver cirrhosis. The aim of the present study was to describe gastric, small intestinal and
colorectal motility and transit in patients with liver cirrhosis and portal hypertension using a magnet-based Motility
Tracking System (MTS-1) and standard radiopaque markers.
Methods: We included 15 patients with liver cirrhosis (8 Child-Pugh A, 6 Child-Pugh B, and 1 Child-Pugh C) and portal
hypertension (11 males, median age 54 years (range 38–73), median hepatic venous pressure gradient 18 mmHg
(range 12–37)), and 18 healthy controls (8 males, median age 58 years (range 34–64)). The gastric emptying time and
small intestinal motility were evaluated by MTS-1, and the total gastrointestinal transit time was assessed by
radiopaque markers and abdominal radiographs.
Results: The velocity through the proximal small intestine was significantly higher in cirrhotic patients (median 1.27
metres (m)/hour, range 0.82–2.68) than in the healthy controls (median 1.00 m/hour, range 0.46–1.88) (p = 0.03).
Likewise, the magnet travelled significantly longer in both fast (p = 0.04) and slow movements (p = 0.05) in the patient
group. There was no significant difference in either gastric emptying time—23 minutes (range 5–131) in patients and
29 minutes (range 10.5–182) in healthy controls (p = 0.43)—or total gastrointestinal transit time—1.6 days (range 0.5–2.9)
in patients and 2.0 days (range 1.0–3.9) in healthy controls (p = 0.33). No correlation was observed between the hepatic
venous pressure gradient and the velocity of the magnet through the small intestine.
Conclusion: Patients with liver cirrhosis and portal hypertension demonstrated faster-than-normal transit through the
proximal small intestine. This may be due to an overactive bowel, as suggested by previous studies.
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Liver cirrhosis is a condition associated with increased
morbidity and mortality. Clinically significant portal
hypertension (>10 mmHg) may lead to decompensation,
with complications such as ascites, oesophageal varices
and hepatic encephalopathy (HE). Spontaneous bacterial
peritonitis (SBP) can further complicate ascites with ab-
dominal and systemic inflammation and lead to poten-
tially fatal complications, such as variceal bleeding and
HE [1].* Correspondence: stinkarl@rm.dk
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reproduction in any medium, provided the orSanchez et al. proposed that gut bacteria may be trans-
located into the peritoneal cavity, contributing to the de-
velopment of SBP [2]. An altered gastro-intestinal transit
time (GITT) may enhance the intestinal bacterial over-
growth, subsequently increasing peritoneal bacterial
translocation [3]. Therefore, small intestinal dysmoti-
lity may be involved in the development of cirrhotic
complications.
Previous studies have suggested that cirrhotic patients
demonstrate a prolonged gastric emptying time and
decreased gastric compliance [4,5]. Other studies have
demonstrated a prolonged total GITT related to compli-
cations of cirrhosis, such as spontaneous bacterial peri-
tonitis and malnutrition [5,6]. Due to the difficulty ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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investigated gastric emptying and colonic transit time
(CTT). The magnet-based Motility Tracking system
(MTS-1) used in this study allows for a minimally inva-
sive description of all segments of the gastrointestinal
canal, including the small intestine [7].
We aimed to examine the small intestinal motility and
transit times of the stomach, small intestine and colorec-
tum separately. We hypothesised that small bowel motil-
ity was reduced and that segmental gastrointestinal




We included patients aged 18–75 years with liver cirrho-
sis of any origin referred for clinical investigation of the
hepatic venous pressure gradient (HVPG) at the Depart-
ment of Medicine V (Hepatology and Gastroenterology),
Aarhus University Hospital, Denmark. If the HVPG was
greater than 12 mmHg, the patient was invited to par-
ticipate in the study. Of 62 consecutive patients, we
included 15 (11 men, median age of 54 years, range be-
tween 38 and 73 years). In total, 38 were excluded be-
cause of comorbidities or the use of medications
affecting bowel function; 6 patients did not wish to par-
ticipate, and 3 patients were not included for practical
reasons. Patients were compared to 18 healthy controls
(8 men, median age of 58 years, range between 34 and
64 years). All patients and healthy volunteers included
were without other known conditions affecting bowel
function, and none had undergone abdominal surgery.
All patient medications with known effects on gastro-
intestinal motility were ceased one day prior to begin-
ning the investigation. All patients were characterised by
their HVPG, Child-Pugh scores, and number of bowel
movements per day.
The study was performed in accordance with the Dec-
laration of Helsinki and was approved by the local ethics
committee (reference number M-20110006). All subjects
gave written informed consent before participation.
Hepatic venous pressure gradient measurement
The portal pressure was measured indirectly by HVPG,
as previously described [8]. Under radiographic guid-
ance, an intravascular pressure catheter was placed in a
hepatic vein through the femoral vein. The free and the
wedged pressures were obtained, and the difference be-
tween them represents the pressure gradient across the
liver [8].
Gastric emptying and small intestinal motility
Gastric emptying, small intestinal transit time, median
velocity of the magnet through the small intestine andcontraction patterns were determined using the magnet-
based Motility Tracking System-1 (MTS-1) (Motilis,
Lausanne, Switzerland) [7]. The MTS-1 system provided
information about gastrointestinal transit times and mo-
tility patterns by detecting the position of an orally
ingested magnetic pill. Subjects ingested a silicon-
covered magnetic pill (6×15 mm, density 1.8 g cm−3). A
detection plate with an array of 4×4 sensors was placed
in front of the subject and gave the position and orienta-
tion of the pill defined by three coordinates (position: x,
y, z) and two angles (θ, ϕ). A 2D assessment was made
on the magnet position within the subject by entering
the detection plate location in relation to anatomical
reference points, thereby defining the pill’s propagating
movements. Two external sensors were placed on the
subject’s neck and thorax, recording respiratory and
movement artefacts.
The magnetic coordinate data were continuously sent
to a computer at a sampling rate of 10 Hz during the in-
vestigation period. Custom-made software was used to
picture the coordinates and angles as waves of different
frequencies and amplitudes in real-time. The waves
depicted by the data from the angles represented the
gastro-intestinal contractions. By assessing this wave pat-
tern, we could determine three different gastro-intestinal
phases: the gastric phase, with a pattern of three con-
tractions min−1 and medium amplitude; the small intes-
tinal phase, with 10–14 contractions min−1 [9] and high
and mixed amplitude; and the colonic phase, with up to
6 contractions min−1 and low amplitude [10]. The move-
ments through the small intestine were divided into the
following three types: fast (>15 cm min−1), slow (between
1.5 and 15 cm min−1) and very slow (<1.5 cm min−1) [10].
The system calibration for ambient magnetic fields
was performed before each recording and subsequently
every 90 minutes. The technical specifications of MTS-1
and data on its validity have recently been published
[7,10].
Experimental protocol for the Motility Tracking System
After eight hours of fasting, investigations with MTS-1
started at 8 A.M. The outer abdominal size was esti-
mated using the distances between the xiphoid process
and the symphysis pubis, the superior iliac spines on
both sides, and the abdominal wall and the back. The
pill was ingested with 100 ml of water. During the mea-
surements, the subject was placed on a wooden bed with
the headboard in an upright position. Measurements
were continued for a minimum of seven hours or until
the magnetic pill was in the caecum. Small breaks for
toilet visits and short walks were permitted at the sub-
jects’ request. The subjects were encouraged to not talk,
sleep or move but were allowed to read or watch TV.
After the magnetic pill had passed to the duodenum, a
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41% carbohydrate) was served. Three hours after break-
fast, a standardised lunch (1.500 kJ, 16% protein, 32%
fat, 52% carbohydrate) was provided. When the mag-
netic pill had passed to the caecum, or after a minimum
of seven hours, the investigation was terminated.
Total gastrointestinal transit time (GITT)
GITT was determined as described by Abrahamsson
et al. [11]. At 12 A.M. for six consecutive days, the pa-
tient ingested a capsule containing 10 radiopaque mar-
kers. On the seventh day, a plain radiography of the
abdomen was taken. The number of markers left in the
different segments of the colon was counted, and the
GITT was calculated based on the following formula:
GITT ¼ M þ f  Dð Þð ÞD
where M is the total number of markers left; D is the
number of markers ingested each day; and f is the frac-
tion of the daily markers selected for the provision of
transit. In this case, f = 0.5.
Data analysis
Two investigators independently evaluated data obtained
by MTS-1, and the mean values were used for all subse-
quent analysis. GE was the time from magnet ingestion
to pyloric passage, identified by the following signs: the
cessation of the characteristic gastric pattern (3 contrac-
tions min−1), the appearance of small intestinal contrac-
tion pattern (10–14 contractions min−1) and the
appearance of the duodenal arch on the 2D representa-
tion (Figure 1). The small intestinal transit time was the
time from pyloric passage to ileocaecal passage, identi-
fied by the cessation of contraction patterns of 10–
14 min−1 and the occurrence of a short, fast movement
of the magnetic pill situated in the lower right quadrant
on the 2D representation. The mean velocity of theFigure 1 Magnetic sensor and duodenal arch. Tracking of the magnetic
coordinates X, Y and Z, and the rotation is defined by the angles ϕ and θ
sequence displayed is 10 seconds long.magnetic pill within the small intestine was determined
using the MTS-1 software MTS Tools (Motilis, Lausanne,
Switzerland) [7].
Statistical analysis
All data are expressed as medians with ranges. GE, small
intestinal propagation velocity and GITT were compared
in the two groups using the Mann Whitney U-test. The
correlations between HVPG and the presence of
oesophageal varices and GI transit times were analysed
using Spearman’s rank correlation. P < 0.05 was consid-
ered statistically significant.
Results
Overall, 15 patients with cirrhosis and portal hyperten-
sion completed the study and were compared to 18
healthy controls. The aetiologies of cirrhosis were alco-
hol (n = 11), non-alcoholic steatohepatitis (n = 2), viral
hepatitis C (n = 1) and primary biliary cirrhosis (n = 1).
The Child-Pugh classifications were A (n = 8), B (n = 6)
and C (n = 1). The median portal pressure was 18 mmHg
(range: 12–37). Additionally, 10 out of 15 patients (67%)
had previously bled from varices; 12 patients had grade
2–3 oesophageal varices; one patient had grade 1
oesophageal varices; and one patient had gastric varices
without signs of oesophageal varices. One patient had
no evidence of either oesophageal or gastric varices.
Two patients with alcohol cirrhosis had current alcohol
intake.
In all patients and healthy subjects, the number of
bowel movements per day and the stool consistency
were within normal limits.
Gastric and intestinal motility
The MTS-1 procedure was well tolerated by all subjects.
The characteristic basic contraction frequencies of 3 min−1
in the stomach and 9–11 min−1 in the small intestine were
observed in all patients and controls. In both groups, thepill by 16 (4x4) external sensors. The position is defined by
(left). 3D representation pyloric and duodenal passage (right). The
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through the small intestine. Data on gastric emptying and
small intestinal motility are shown in Table 1. There was
no significant difference in the median fasting state gastric
emptying time between patients and healthy controls
(p = 0.43). the magnet propagation velocity during the
first two hours in the small intestine was significantly
faster in patients than in healthy controls (p = 0.03).
All participants stated that they had followed the
protocol for the assessment of GITT. The median GITT
was 1.6 days (range 0.5–2.9) in patients and 2.0 days
(range 1.0–3.9) in healthy controls (p = 0.33). GITT was
more than 3 days in one healthy subject (3.4 days), while
none of the patients had a GITT longer than 3 days.
Portal hypertension and small intestinal motility
We found no correlation between the degree of portal
hypertension and the velocity of the magnetic pill
through the small intestine (r = −0.29, p = 0.29). There
was no difference in the propagation velocity during the
first two hours between the patients with no or grade 1
oesophageal varices and those with grade 2–3 oesophageal
or gastric varices (p = 0.93).
Discussion
In the present study, we evaluated the small intestinal
motility and transit in patients with liver cirrhosis and
clinically significant portal hypertension. We used a
novel magnet-based MTS-1 that provides detailed infor-
mation on intestinal motility. Our main finding was that
patients with cirrhosis and portal hypertension had
faster-than-normal postprandial transit through the
proximal small intestine. Thus, our hypothesis of
reduced small bowel motility and prolonged segmental
gastrointestinal transit times was rejected.
The basic and highly characteristic contraction fre-
quencies of the stomach and small intestine were un-
altered by portal hypertension, but the distance was
covered faster both during the long periods withTable 1 Gastrointestinal motility and transit times in patients
Gastric emptying time (minutes)
Magnet velocity during first 2 hours in the small intestine (meters/hour)
Magnet velocity during first 4 hours in the small intestine (meters/hour)
Total gastrointestinal transit time (days)
Duration of time in the small intestine with fast movements (minutes)
Distance travelled during fast movements during the first 4 hours (meters)
Duration of time in the small intestine with slow movements (minutes)
Distance travelled during slow movements during the first 4 hours (meters)
Basic frequency of small intestinal contractions (contractions/minute)
The magnet pill moved faster through the upper small intestine in patients than inrelatively slow transit and during the short bursts of very
fast movement. Madsen et al. studied eight patients with
cirrhosis and portal hypertension using scintigraphy
[12]. They found no difference in the GE of solids or
small intestinal transit times compared to healthy con-
trols. The scintigraphy technique is considered the gold
standard for measuring GI transit times. However,
standard 30 minute-intervals between each image were
used, and smaller differences in either GE or small intes-
tinal transit times could thus have been missed. In the
same study, cirrhosis patients showed faster-than-
normal colonic transit times [12]. It has previously been
demonstrated that patients with cirrhosis have a pro-
longed phase II of the fasting small intestinal migrating
motor complex (MMC) [13]. We obtained data on small
intestinal motility in the postprandial state, but our data
also suggest an abnormally active small intestine in
patients with liver cirrhosis.
Some previous studies have suggested that patients
with liver cirrhosis have prolonged GE [14,15], while
others found no difference [16]. The main focus of the
present study was small intestinal motility, aiming for an
exact determination of pyloric passage that MTS-1 pro-
vides [10]. As a detailed evaluation of GE should be per-
formed in both the solid and the liquid phases, MTS-1
is not ideal for the description of GE. Large particles will
typically pass through the pylorus during phase III of the
migrating motor complex [17]. Unless magnet intake is
standardised with respect to MMC or with a meal, a
large variation in solid-state GE should be expected, as
observed in the present study.
Our findings are in contrast with some previous stud-
ies that demonstrated prolonged gastrointestinal transit
times in patients with liver cirrhosis. However, those
studies investigated the total orocaecal transit times with
radiopaque markers [6] or lactulose breath tests [18].
These methods do not differentiate between GE and
small intestinal transit time, and differences in small in-
testinal transit may not be detected, especially if GE iswith liver cirrhosis and in healthy controls
Patients with cirrhosis Healthy controls p
23 (5–131) 29 (11–182) 0.43
1.27 (0.82–2.68) 1.00 (0.46–1.88) 0.03
0.95 (0.60–1.79) 0.75 (0.30–1.34) 0.06
1.6 (0.5–2.9) 2.0 (1.0–3.9) 0.33
8 (3–18) 6 (2–14) 0.16
1.97 (1.28–4.98) 1.47 (0.27–3.23) 0.04
50 (19–87) 38 (10–76) 0.45
1.27 (0.58–2.07) 0.89 (0.30–1.66) 0.05
9.5 (8.8–10.9) 9.8 (8.7–10.4) 0.18
healthy controls. All data expressed as median (range).
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often suffer from small intestinal bacterial overgrowth,
making the lactulose breath test unreliable [19]. Other
studies have shown both prolonged and reduced colonic
transit times in cirrhotic patients [6,20]. However, GITT
mainly reflects colonic transit time, and in our study,
there was no difference in GITT between patients with
cirrhosis and controls.
It has previously been shown that a history of SBP cor-
relates to the degree of GI alterations in patients with
liver cirrhosis [21]. Additionally, there are indications
that abnormalities in small intestinal motility are related
to the degree of chronic liver failure [5]. In accordance
with the present study, Madsen et al. found no correl-
ation between transit times and HVPG [12]. However,
this may be a type II error due to the small number of
patients included in both studies.
Our findings were surprising and contrary to our hy-
pothesis. It is unclear through which mechanisms portal
hypertension may affect gastrointestinal motility. It may
be that portal vein and intestinal wall blood stasis may
cause an overactive bowel. We studied small intestinal
motility in the postprandial state. In the fasting state, a
marked change in the contraction patterns of phase II
and the MMC has been previously observed [13].
Whether this behaviour indicates an overactive bowel is
unknown. In healthy individuals, intestinal peristalsis,
gastric acid and mucosal immunity act to protect the
small intestine from bacterial overgrowth and transloca-
tion. Breath tests for small intestine bacterial overgrowth
are not reliable for research purposes [22], and cultures
from small intestinal fluid require invasive investigation.
For these reasons, we did not investigate whether
patients in the present study had small intestine bacterial
overgrowth.
Previous studies have suggested that the aetiology of
liver cirrhosis may influence GI transit times [3,23]. In
the present study, we included patients consecutively
and independently of cirrhosis aetiology. The mixed aeti-
ology and differing representation of Child-Pugh classes
in a small sample size are major limitations of the study.
The main aetiology of cirrhosis was alcohol consump-
tion, and it is well known that alcohol may affect gastro-
intestinal motility. However, all but two patients had
abstained from drinking for at least 3 months prior to
the investigation. Pancreatic insufficiency may also re-
duce small intestinal transit. However, none of the
patients had a history of acute or chronic pancreatitis or
malabsorption, and no signs of calcification in the pan-
creatic area were noticed on abdominal radiographs.
Furthermore, autonomic dysfunction in patients with
liver cirrhosis may lead to gastroparesis and an abnormal
frequency of gastric contractions [24]. Compared to
healthy controls, we found no differences in thecontraction frequency in either the stomach or the small
intestine.
There was a difference in gender between our patients
and the control group. However, when stratifying the data
in each group by gender, we could not detect any differ-
ences in GE, small intestinal velocity or colonic transit
time. Ten out of 15 patients had a history of bleeding
oesophagus varices. Oesophago-gastro-doudenoscopy had
been performed in all patients, and 14 had oesophageal
varices. We found no association between the presence of
varices and motility patterns.
Conclusion
In conclusion, our findings indicate that GI transit is ab-
normally fast in the proximal small intestine of patients
with liver cirrhosis and portal hypertension. More and
larger studies are needed to confirm our findings and to
determine the mechanisms of action. Furthermore, the
associations among gastrointestinal dysmotility, bacterial
overgrowth and the risk of cirrhotic complications
should be studied.
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